EphA2 receptor tyrosine kinase regulates endothelial cell migration and vascular assembly through phosphoinositide 3-kinase-mediated Rac1 GTPase activation

被引:170
作者
Brantley-Sieders, DM
Caughron, J
Hicks, D
Pozzi, A
Ruiz, JC
Chen, J [1 ]
机构
[1] Vanderbilt Univ, Sch Med, Div Rheumatol & Immunol, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Sch Med, Div Nephrol, Dept Med, Nashville, TN 37232 USA
[3] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37232 USA
[4] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37232 USA
[5] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA
[6] Maryville Coll, Dept Chem, Maryville, TN USA
[7] Indiana Univ, Sch Med, Dept Pediat, Indianapolis, IN 46202 USA
关键词
EphA2; Ephrin-A1; endothelial cell; Rac1; P13-kinase; angiogenesis;
D O I
10.1242/jcs.01061
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Angiogenesis is critical for vascular remodeling during development and contributes to the pathogenesis of diseases such as cancer. Targeted disruption of several EphB class receptor tyrosine kinases results in vascular remodeling defects during embryogenesis. The role of EphA class receptors in vascular remodeling, however, is not well-characterized. We recently demonstrated that global inhibition of EphA receptors disrupts endothelial migration induced by ephrin, VEGF or tumor-derived signals, though the specific target remained undefined. Here, we report that EphA2 regulates endothelial cell assembly and migration through phosphoinositide (PI) 3-kinase-mediated activation of Rac1 GTPase in two model systems: primary bovine and murine pulmonary microvascular endothelial cells. EphA2-deficient endothelial cells fail to undergo vascular assembly and migration in response to ephrin-A1 in vitro. Ephrin-A1 stimulation induces PI3-kinase-dependent activation of Rac1 in wild-type endothelial cells, whereas EphA2-deficient cells fail to activate Rac1 upon stimulation. Expression of dominant negative PI3-kinase or Rac1 inhibits ephrin-A1-induced endothelial cell migration. Consistent with in vitro data, EphA2-deficient mice show a diminished angiogenic response to ephrin-A1 in vivo. Moreover, EphA2-deficient endothelial cells fail to assemble in vivo when transplanted into recipient mice. These data suggest that EphA2 is an essential regulator of post-natal angiogenesis.
引用
收藏
页码:2037 / 2049
页数:13
相关论文
共 41 条
  • [1] Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis
    Adams, RH
    Wilkinson, GA
    Weiss, C
    Diella, F
    Gale, NW
    Deutsch, U
    Risau, W
    Klein, R
    [J]. GENES & DEVELOPMENT, 1999, 13 (03) : 295 - 306
  • [2] Cytoskeletal effects of Rho-like small guanine nucleotide-binding proteins in the vascular system
    Amerongen, GPV
    van Hinsbergh, VWM
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (03) : 300 - 311
  • [3] Inhibition of RhoA by p120 catenin
    Anastasiadis, PZ
    Moon, SY
    Thoreson, MA
    Mariner, DJ
    Crawford, HC
    Zheng, Y
    Reynolds, AB
    [J]. NATURE CELL BIOLOGY, 2000, 2 (09) : 637 - 644
  • [4] Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo
    Brantley, DM
    Cheng, N
    Thompson, EJ
    Lin, Q
    Brekken, RA
    Thorpe, PE
    Muraoka, RS
    Cerretti, DP
    Pozzi, A
    Jackson, D
    Lin, C
    Chen, J
    [J]. ONCOGENE, 2002, 21 (46) : 7011 - 7026
  • [5] The phosphoinositide 3-kinase pathway
    Cantley, LC
    [J]. SCIENCE, 2002, 296 (5573) : 1655 - 1657
  • [6] Cantrell DA, 2001, J CELL SCI, V114, P1439
  • [7] Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions
    Carmeliet, P
    Moons, L
    Luttun, A
    Vincenti, V
    Compernolle, V
    De Mol, M
    Wu, Y
    Bon, F
    Devy, L
    Beck, H
    Scholz, D
    Acker, T
    DiPalma, T
    Dewerchin, M
    Noel, A
    Stalmans, I
    Barra, A
    Blacher, S
    Vandendriessche, T
    Ponten, A
    Eriksson, U
    Plate, KH
    Foidart, JM
    Schaper, W
    Charnock-Jones, DS
    Hicklin, DJ
    Herbert, JM
    Collen, D
    Persico, MG
    [J]. NATURE MEDICINE, 2001, 7 (05) : 575 - 583
  • [8] Chen J, 1996, ONCOGENE, V12, P979
  • [9] Cheng N, 2002, MOL CANCER RES, V1, P2
  • [10] Inhibition of VEGF-dependent multistage carcinogenesis by soluble EphA receptors
    Cheng, N
    Brantley, D
    Bin Fang, W
    Liu, H
    Fanslow, W
    Cerretti, DP
    Bussell, KN
    Reith, AD
    Jackson, D
    Chen, J
    [J]. NEOPLASIA, 2003, 5 (05): : 445 - 456